Grace Therapeutics, Inc.

New Filing
CIK: 0001444192·Pharmaceuticals·DELAWARE·Filed: Aug 10, 2026
Total Offering

$9,999,998

Amount Sold

$9,999,998

Investors

9

First Sale

Aug 4, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Prashant Kohli
Vimal Kavuru
Robert J. DelAversano
A. Brian Davis
S. George Kottayil
Edward Neugeboren
Dr. R. Loch Macdonald
Amresh Kumar

Company

Grace Therapeutics, Inc.

103 CARNEGIE CENTER

PRINCETON, NJ, 08540

609-322-1602

SEC Filing

0001123292-26-001084

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free